Skip to main content

David Basiji, Jack Ball, Kevin Hrusovsky, Robert Hurley, Paulette Gray

Premium

David Basiji has been named CEO of Amnis, Cell-Based Assay News has learned. Basiji was previously Amnis' chief technology officer. He replaces former CEO Jack Ball. Further details about Ball's departure were not available.


Xenogen said last week that it has elected Kevin Hrusovsky to its board of directors. Hrusovsky will also join Xenogen's nominating and governance committee following its

Hrusovsky has been CEO of Caliper Life Sciences since it acquired Zymark in the summer of 2003. Prior to the acquisition, Hrusovsky held management positions at FMC Corporation and E.I. DuPont de Nemours, Xenogen said. He holds a BS in mechanical engineering from Ohio State University, an MBA from Ohio University, and an extended MBA from Harvard University.


Beckman Coulter said last week that Robert Hurley has been named vice president of human resources and corporate communications effective May 23.

Hurley joins Beckman Coulter from Baxter International, where he is currently corporate vice president of restructuring. Hurley joined Baxter/American Hospital Supply in 1980, and held various positions in the company, including vice president of human resources, and corporate vice president and president of Baxter Japan/China. He holds a BA in political science from the University of Georgia, and served as a captain in the US Army from 1971 to 1980.


Paulette Gray has become director of the division of extramural activities of the National Cancer Institute, NCI said last week. She had been the division's deputy director, then acting and deputy director, since 1997. The division of extramural activities coordinates all of NCI's extramural programs and grants. Gray joined NCI in 1984 as a special review officer, moving to different positions from there. She holds a PhD in cellular and developmental biology and an MS in mycology from Atlanta University, and a BS in biology from Tuskegee University in Alabama.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.